BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
Abstract Background Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its intrinsic heterogeneity and lack of effective targets, it is crucial to identify novel molecular targets that would increase RT efficacy. Her...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-06-01
|
| Schriftenreihe: | Journal of Experimental & Clinical Cancer Research |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13046-024-03086-9 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|